TOVX vs ULTA · rev $300.0K vs P/E 17, rev $3.04B
Theriva Biologics Inc. (TOVX) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
TOVX currently screens at market cap $12.4M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the TOVX and ULTA stock pages for the full models.
Not investment advice.